Literature DB >> 30817058

Sleep, emotional distress, and physical health in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.

Lauren C Daniel1, Mingjuan Wang2, Daniel A Mulrooney3, Deo Kumar Srivastava2, Lisa A Schwartz4,5, Kim Edelstein6, Tara M Brinkman2,3, Eric S Zhou7,8, Rebecca M Howell9, Todd M Gibson3, Wendy Leisenring10, Kevin C Oeffinger11, Joseph Neglia12, Leslie L Robison3, Gregory T Armstrong3, Kevin R Krull2,3.   

Abstract

OBJECTIVE: Sleep disorders are associated with psychological and physical health, although reports in long-term survivors of childhood cancer are limited. We characterized the prevalence and risk factors for behaviors consistent with sleep disorders in survivors and examined longitudinal associations with emotional distress and physical health outcomes.
METHODS: Survivors (n = 1933; median [IQR] age = 35 [30, 41]) and siblings (n = 380; age = 33 [27, 40]) from the Childhood Cancer Survivor Study completed measures of sleep quality, fatigue, and sleepiness. Emotional distress and physical health outcomes were assessed approximately 5 years before and after the sleep survey. Multivariable logistic or modified Poisson regression models examined associations with cancer diagnosis, treatment exposures, and emotional and physical health outcomes.
RESULTS: Survivors were more likely to report poor sleep efficiency (30.8% vs 24.7%; prevalence ratio [PR] = 1.26; 95% confidence interval, 1.04-1.53), daytime sleepiness (18.7% vs 14.2%; PR = 1.31 [1.01-1.71]), and sleep supplement use (13.5% vs 8.3%; PR = 1.56 [1.09-2.22]) than siblings. Survivors who developed emotional distress were more likely to report poor sleep efficiency (PR = 1.70 [1.40-2.07]), restricted sleep time (PR = 1.35 [1.12-1.62]), fatigue (PR = 2.11 [1.92-2.32]), daytime sleepiness (PR = 2.19 [1.71-2.82]), snoring (PR = 1.85 [1.08-3.16]), and more sleep medication (PR = 2.86 [2.00-4.09]) and supplement use (PR = 1.89[1.33-2.69]). Survivors reporting symptoms of insomnia (PR = 1.46 [1.02-2.08]), fatigue (PR = 1.31 [1.01-1.72]), and using sleep medications (PR = 2.16 [1.13-4.12]) were more likely to develop migraines/headaches.
CONCLUSIONS: Survivors report more sleep difficulties and efforts to manage sleep than siblings. These sleep behaviors are related to worsening or persistently elevated emotional distress and may result in increased risk for migraines. Behavioral interventions targeting sleep may be important for improving health outcomes.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer; childhood cancer survivors; emotional distress; late effects; oncology; sleep

Mesh:

Year:  2019        PMID: 30817058      PMCID: PMC6506232          DOI: 10.1002/pon.5040

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  16 in total

1.  Association of Demographic and Cancer-Specific Factors on Health Behavior Recommendations Specific to Cancer Prevention and Control Among Adolescent and Young Adult Survivors of Childhood Cancer.

Authors:  Katie Darabos; Lamia P Barakat; Marilyn Schapira; Christine Hill-Kayser; Lisa A Schwartz
Journal:  J Adolesc Young Adult Oncol       Date:  2020-11-18       Impact factor: 2.223

2.  Concordance between self-reported sleep and actigraphy-assessed sleep in adult survivors of childhood cancer: the impact of psychological and neurocognitive late effects.

Authors:  Margaret M Lubas; Mariana Szklo-Coxe; Belinda N Mandrell; Carrie R Howell; Kirsten K Ness; Deo Kumar Srivastava; Melissa M Hudson; Leslie L Robison; Kevin R Krull; Tara M Brinkman
Journal:  Support Care Cancer       Date:  2021-08-26       Impact factor: 3.603

3.  A randomized double-blind placebo-controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer.

Authors:  Margaret M Lubas; Belinda N Mandrell; William L Greene; Carrie R Howell; Robbin Christensen; Cara I Kimberg; Chenghong Li; Kirsten K Ness; Deo Kumar Srivastava; Melissa M Hudson; Leslie L Robison; Kevin R Krull; Tara M Brinkman
Journal:  Pediatr Blood Cancer       Date:  2021-10-21       Impact factor: 3.167

4.  Informing Parents as Caregivers With a Symptom Assessment App Developed for Children With Cancer.

Authors:  Katherine M Bernier Carney; Kristin Stegenga; Lauri A Linder
Journal:  J Pediatr Hematol Oncol Nurs       Date:  2022-02-15

5.  Efficacy of Mobile Instant Messaging-Delivered Brief Motivational Interviewing for Parents to Promote Physical Activity in Pediatric Cancer Survivors: A Randomized Clinical Trial.

Authors:  Ankie Tan Cheung; William Ho Cheung Li; Laurie Long Kwan Ho; Godfrey Chi-Fung Chan; Huen Sum Lam; Joyce Oi Kwan Chung
Journal:  JAMA Netw Open       Date:  2022-06-01

6.  Prevalence of Sleep Disorders, Risk Factors and Sleep Treatment Needs of Adolescents and Young Adult Childhood Cancer Patients in Follow-Up after Treatment.

Authors:  Shosha H M Peersmann; Martha A Grootenhuis; Annemieke van Straten; Gerard A Kerkhof; Wim J E Tissing; Floor Abbink; Andrica C H de Vries; Jacqueline Loonen; Leontien C M Kremer; Gertjan J L Kaspers; Raphaële R L van Litsenburg
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

Review 7.  Advances in pediatric psychooncology.

Authors:  Lori Wiener; Katie A Devine; Amanda L Thompson
Journal:  Curr Opin Pediatr       Date:  2020-02       Impact factor: 2.856

8.  Short sleep duration and physical and psychological health outcomes among adult survivors of childhood cancer.

Authors:  Margaret M Lubas; Belinda N Mandrell; Kirsten K Ness; Deo Kumar Srivastava; Matthew J Ehrhardt; Zhaoming Wang; Melissa M Hudson; Leslie L Robison; Kevin R Krull; Tara M Brinkman
Journal:  Pediatr Blood Cancer       Date:  2021-04-06       Impact factor: 3.838

9.  Severe fatigue after treatment for childhood cancer.

Authors:  Sylvia van Deuren; Amilie Boonstra; Eline van Dulmen-den Broeder; Nicole Blijlevens; Hans Knoop; Jacqueline Loonen
Journal:  Cochrane Database Syst Rev       Date:  2020-03-03

Review 10.  Physical activity for pediatric cancer survivors: a systematic review of randomized controlled trials.

Authors:  Ankie Tan Cheung; William Ho Cheung Li; Laurie Long Kwan Ho; Ka Yan Ho; Godfrey Chi Fung Chan; Joyce Oi Kwan Chung
Journal:  J Cancer Surviv       Date:  2021-01-03       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.